Recent advances in neuromuscular blocking agents

American Journal of Health-System Pharmacy

Volumn 56, Issue 11 SUPPL. 1, 1999, Pages

  Bartkowski, Richard R ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Clinical studies; Duration of action; Pharmacodynamics; Pharmacokinetics; Potency; Rapacuronium; Skeletal muscle relaxants; Toxicity

Indexed keywords

CISATRACURIUM; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; RAPACURONIUM BROMIDE; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

CONFERENCE PAPER; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG POTENCY; DRUG RESEARCH; HUMAN; MEMBRANE DEPOLARIZATION; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL;

EID: 0033153379     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.s14     Document Type: Conference Paper

References (8)

1. Fisher DM. Clinical pharmacology of neuromuscular blocking agents. Am J Health-Syst Pharm. 1999; 56(suppl 1):S4-9.
2. Bevan DR, Bevan JC, Donata F, eds. Muscle relaxants in clinical anesthesia. Chicago: Year Book Publishers; 1988.
3. Silverman DG, ed. Neuromuscular block in perioperative and intensive care. Philadelphia: Lippincott; 1994.
4. Savarese JJ. Some considerations on the new muscle relaxants. Anesth Analg. 1998; 86(suppl):119-27.
5. Bowman WC, Rodger IW, Houston J et al. Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology. 1988; 69:57-62.
6. Bartkowski RR, Witkowski TA, Azad S et al. Rocuronium onset of action: a comparison with atracurium and vecuronium. Anesth Analg. 1993; 77:574-8.
7. Witkowski T, Bartkowski R, Huffnagle S et al. Onset and recovery of rapacuronium: a comparison with rocuronium. Anesthesiology. 1998; 89(3A):A978. Abstract.
8. Bevan DR. Monitoring and reversal of neuromuscular block. Am J Health-Syst Pharm. 1999; 56:S10-3.